Clinical Decision Support for Diabetic Foot Ulcers
The Growing Problem of Diabetic Foot Ulcers
- Diabetic Foot Ulcers (DFUs) are a problem that affects 9.1 million to 26.1 million patients worldwide.
- Undiagnosed, misdiagnosed, or untreated DFUs, both complicate and extend length of care.
Evaluation and Diagnosis
Currently, there are no diagnostic imaging products that utilize AI technology that provide clinicians with an objective and immediate assessment of a DFUs healing potential. Therefore, healthcare professionals rely on subjective assessments based on their experience to determine if wounds, such as diabetic foot ulcers, will respond to treatment.
Predicting DFU’s Healing
Currently, there are no diagnostic tools available for wound healing prediction
Where We Come In
Spectral AI Provides
Clinical Decision Support for Wound Healing
DeepView® is designed to allow clinicians to make a highly accurate, timely and informed decision regarding the treatment of a patient’s wound. Spectral AI’s DeepView® technology allows quicker time to advance therapy, which in turn reduces overall clinician visits while improving patient satisfaction.
Spectral AI’s DeepView technology provides 86% accuracy in predicting if a DFU will close 50% by week 4.
More about Deepview
Learn more about our DeepView® technology
Request a Demo
Looking to learn more about DeepView® technology, or eager to see it in action?